GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Healthcare Co Ltd (XKRX:299480) » Definitions » Cash Flow from Investing

G&E Healthcare Co (XKRX:299480) Cash Flow from Investing : ₩0.00 Mil (TTM As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is G&E Healthcare Co Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in . 20, G&E Healthcare Co spent ₩0.00 Mil on purchasing property, plant, equipment. It gained ₩0.00 Mil from selling property, plant, and equipment. It spent ₩0.00 Mil on purchasing business. It gained ₩0.00 Mil from selling business. It spent ₩0.00 Mil on purchasing investments. It gained ₩0.00 Mil from selling investments. It paid ₩0.00Mil for net Intangibles purchase and sale. And it paid ₩0.00 Mil for other investing activities. In all, G&E Healthcare Co gained ₩0.00 Mil on investment activities in financial market and operating subsidiaries for the six months ended in . 20.


G&E Healthcare Co Cash Flow from Investing Historical Data

The historical data trend for G&E Healthcare Co's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Healthcare Co Cash Flow from Investing Chart

G&E Healthcare Co Annual Data
Trend
Cash Flow from Investing

G&E Healthcare Co Semi-Annual Data
Cash Flow from Investing

G&E Healthcare Co Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

G&E Healthcare Co's Cash Flow from Investing for the fiscal year that ended in . 20 is calculated as:

G&E Healthcare Co's Cash Flow from Investing for the quarter that ended in . 20 is calculated as:


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Investing for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G&E Healthcare Co  (XKRX:299480) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

G&E Healthcare Co's purchase of property, plant, equipment for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co spent ₩0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

G&E Healthcare Co's sale of property, plant, equipment for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co gained ₩0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

G&E Healthcare Co's purchase of business for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co spent ₩0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

G&E Healthcare Co's sale of business for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co gained ₩0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

G&E Healthcare Co's purchase of investment for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

G&E Healthcare Co's sale of investment for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co gained ₩0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

G&E Healthcare Co's net Intangibles purchase and sale for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co paid ₩0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

G&E Healthcare Co's cash from discontinued investing activities for the six months ended in . 20 was 0.00 Mil. It means G&E Healthcare Co paid ₩0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

G&E Healthcare Co's cash from other investing activities for the six months ended in . 20 was ₩0.00 Mil. It means G&E Healthcare Co paid ₩0.00 Mil for other investing activities.


G&E Healthcare Co Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of G&E Healthcare Co's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Healthcare Co (XKRX:299480) Business Description

Traded in Other Exchanges
N/A
Address
No. 92, Keji 5th Road, Annan District, Tainan, TWN, 70955
G&E Healthcare Co Ltd, formerly G&E Biotech Co Ltd is a biopharmaceutical company focused on the development and commercialization of novel botanical extraction technology and products. It offers a range of products that include Hepato Protective Agent (Hepanamin) which prevent and cure for acute and chronic hepatitis, fatty liver conditions and liver toxicity infections, Botanical Healthcare product, and Botanical Anti-aging cosmetics.

G&E Healthcare Co (XKRX:299480) Headlines

No Headlines